A personalized therapeutic approach for cancer containing the African-centric P47S variant of TP53
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 18 samples: 18 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE311354_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1369191 and SRA study SRP648794. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 18 sample titles: 18 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9324013 1_WT-HepG2-DMSO-control_1
- GSM9324014 2_WT-HepG2-DMSO-control_2
- GSM9324015 3_WT-HepG2-DMSO-control_3
- GSM9324016 4_5B4-HepG2--DMSO-control_1
- GSM9324017 5_5B4-HepG2--DMSO-control_2
- GSM9324018 6_5B4-HepG2--DMSO-control_3
- GSM9324019 7_WT-HepG2-10-uM-Lexi-8-hrs_1
- GSM9324020 8_WT-HepG2-10-uM-Lexi-8-hrs_2
- GSM9324021 9_WT-HepG2-10-uM-Lexi-8-hrs_3
- GSM9324022 10_5B4-HepG2-10-uM-Lexi-8-hrs_1
- GSM9324023 11_5B4-HepG2-10-uM-Lexi-8-hrs_2
- GSM9324024 12_5B4-HepG2-10-uM-Lexi-8-hrs_3
- GSM9324025 13_WT-HepG2-10-uM-Lexi-24-hrs_1
- GSM9324026 14_WT-HepG2-10-uM-Lexi-24-hrs_2
- GSM9324027 15_WT-HepG2-10-uM-Lexi-24-hrs_3
- GSM9324028 16_5B4-HepG2-10-uM-Lexi-24-hrs_1
- GSM9324029 17_5B4-HepG2-10-uM-Lexi-24-hrs_2
- GSM9324030 18_5B4-HepG2-10-uM-Lexi-24-hrs_3
- GSE297670 Splice-altering TP53 missense mutations: Drivers of functional loss and therapeutic targets via RNA modulation 18 samples shares tp53, therapeutic
- GSE277585 The Ashkenazi-centric G334R variant of TP53 is severely impaired for transactivation but retains tumor suppressor function in a mouse model [RNA-seq] 18 samples shares tp53, variant
- GSE277586 The Ashkenazi-centric G334R variant of TP53 is severely impaired for transactivation but retains tumor suppressor function in a mouse model [ChIP-Seq] 44 samples shares tp53, variant
- GSE268641 Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics 15 samples shares personalized, therapeutic
- GSE268639 Development of a Cellular Assay as a Personalized Model for Testing Chronic Wound Therapeutics (NS79) 9 samples shares personalized, therapeutic
- GSE290610 High-throughput 3D glioblastoma model for rapid personalized therapeutic screening 6 samples shares personalized, therapeutic
- GSE306117 Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers 74 samples shares tp53
- GSE262053 Charting the regulatory landscape of TP53 on transposable elements in cancer [RNA-seq] 72 samples shares tp53
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.